Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2044-2023Class II

RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief

Appliedvr / initiated 2023-02-27 / Completed / root cause: software

Appliedvr began a recall of RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief on . FDA classified it as Class II and gives the reason as "There is the potential for the program software to malfunction which will not allow it to move forward to the next session". As of , the recall status on record is Completed, and MDM tags the root cause as software.

Recall record

Recall number
Z-2044-2023
Classification
Class II
Status
Completed
Initiated
Posted
Recalling firm
Appliedvr
Product
RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief.
Product code
QRA Virtual Reality Behavioral Therapy Device For Pain Relief
Reason for recall
There is the potential for the program software to malfunction which will not allow it to move forward to the next session.
Root cause tag
software
FDA root cause
Software Manufacturing/Software Deployment
Action
On May, 2, 2023, AppliedVR provided customers with a Medical Device Recall notification in person. The recall notification informed the customer that the device was being recalled. For questions contact AppliedVR or your Health Care Provider.
Quantity in commerce
1 unit
Distribution
US: NY OUS: None
Product codes and lots
Serial Number: PA7940RGG5130514B; UDI: 0100850038247027211001077

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2044-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2044-2023Class IICompletedVoluntary: Firm initiated